menu ☰
menu ˟

VIDEO: Researchers encouraged by number needed to treat with abaloparatide

24 Aug 2017
ATLANTA — In this video exclusive, E. Michael Lewiecki, MD, FACP, FACE, director of New Mexico Clinical Research and Osteoporosis Center in Albuquerque, discusses the new osteoporosis drug abaloparatide, a synthetic form of human parathyroid hormon...

Click here to view the full article which appeared in Endocrinology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.